The global medical devices market size was USD 604.20 billion in 2023, calculated at USD 640.45 billion in 2024 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Devices Market
5.1. COVID-19 Landscape: Medical Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Devices Market, By Product
8.1. Medical Devices Market, by Product Type, 2024-2034
8.1.1. Monitoring Devices
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Diagnostic Devices
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Surgical ENT Devices
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Endoscopes
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Imaging Devices
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Diagnostic Molecular Devices
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Drug Delivery Devices
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Surgical Devices
8.1.8.1. Market Revenue and Forecast (2021-2034)
8.1.9. Bio Implants and Stimulation Devices
8.1.9.1. Market Revenue and Forecast (2021-2034)
8.1.10. Surgical ENT Devices.
8.1.10.1. Market Revenue and Forecast (2021-2034)
8.1.11. Treatment Equipment
8.1.11.1. Market Revenue and Forecast (2021-2034)
8.1.12. Infusion Pumps
8.1.12.1. Market Revenue and Forecast (2021-2034)
8.1.13. Medical lasers and LASIK Surgical Machines
8.1.13.1. Market Revenue and Forecast (2021-2034)
8.1.14. Drug Delivery Devices
8.1.14.1. Market Revenue and Forecast (2021-2034)
8.1.15. Others
8.1.15.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Medical Devices Market, By Therapeutic Application
9.1. Medical Devices Market, by Therapeutic Application, 2024-2034
9.1.1. Gastrointestinal surgery
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. General Surgery
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Diagnostic Imaging
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Respiratory
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Orthopedics
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Cardiovascular
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Dental
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.8. Neurology
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Ophthalmology
9.1.9.1. Market Revenue and Forecast (2021-2034)
9.1.10. Ear-Nose-Throat (ENT)
9.1.10.1. Market Revenue and Forecast (2021-2034)
9.1.11. Nephrology and Urology
9.1.11.1. Market Revenue and Forecast (2021-2034)
9.1.12. Others
9.1.12.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Medical Devices Market, By End User
10.1. Medical Devices Market, by End User, 2024-2034
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Diagnostic Centers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Research laboratory
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Pharmaceutical Companies
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Medical Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.1.3. Market Revenue and Forecast, by End User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.2.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.3.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.5.3. Market Revenue and Forecast, by End User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Therapeutic Application (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End User (2021-2034)
Chapter 12. Company Profiles
12.1. Medtronics Plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Johnson & Johnson
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Fesenius Medical Care
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. DePuy Synthes
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Abbott Laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Philips Healthcare
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ethicon LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Siemens Healthineers AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Stryker
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Cardinal Health
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Baxter International Inc.
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. BD
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample